Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Merck & Co Inc 価格の生配信データ
The current price of Merck & Co Inc in the market is ¥13,222.37, with a 24-hour trading volume of ¥45.72M. The asset's market cap is ¥33.02T, after moving 0.23% in the last day.